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The Warburg effect is an explosive area of study within the cancer community in 
recent years. The expanding knowledge on the molecular basis of the Warburg effect 
has also led to a greater understanding of mammalian retinal metabolism, and at the 
same time has also motivated cancer researchers to target the Warburg effect as a 
novel treatment strategy for cancer. However, the key aspects of the molecular 
mechanism underlying the Warburg effect are likely conserved between the retina and 
cancer. Therefore, cancer treatments targeting the Warburg effect may potentially 
have serious adverse effects on retinal metabolism. Herein, we provide an updated 













Introduction   
In the 1920s, Otto Warburg and his team at the Kaiser Wilhelm Institute showed that 
cancer cells tend to convert glucose to lactate, despite the presence of oxygen. He 
called this phenomenon “aerobic glycolysis”, a term which is now synonymous with 
the “Warburg effect” (Fig. 1).  Warburg believed that this phenomenon was 
abnormal: a breach of the “Pasteur effect” where oxygen inhibits glycolysis, or 
conversely, hypoxia stimulates glycolysis.
2,3
 He further believed that the switch from 
oxidative phosphorylation (OXPHOS) to glycolysis caused cancer,
1
 a concept that 
was criticized during his lifetime, but that has recently had a resurgence. His team 
also noted that normal mammalian retinal explants displayed aerobic glycolysis.
4
 This 
finding however did not fit neatly with Warburg’s beliefs about cancer pathogenesis 
and was attributed as an experimental artifact. Several decades thereafter, other 





In recent years, the Warburg effect has become an explosive area of study within the 
cancer research community, with many publications in the world’s leading scientific 
journals,
7-10
 resulting in a deeper understanding of the Warburg effect at the molecular 
level. This new knowledge has also led to better comprehension of the presence of the 
Warburg effect in mammalian retina.
11
 However, the fact that the retina also displays 
the Warburg effect is rarely acknowledged in the cancer literature. For example, the 
authors of a Nature Reviews Cancer publication incorrectly stated that “aerobic 
glycolysis is uniquely observed in cancer”. 12 But the Warburg effect is widely 
described in other cell types namely embryonic stem cells, human T lymphocytes, 





With cancer researchers enthusiastically attempting to target the Warburg effect as a 
therapeutic strategy in cancer treatment, the misconception that it is unique to cancer 
could potentially lead to treatments that have serious adverse effects on these 
physiological tissues and cells. In this review we aim to provide an updated 
understanding of the Warburg effect in the mammalian retina. 
 
Aerobic Glycolysis 
Cellular metabolism and the Warburg effect 
All life on Earth uses adenosine triphosphate (ATP) to transfer energy. ATP is 
generated via two related metabolic pathways: OXPHOS and glycolysis.
15
 Glycolysis 
converts a single molecule of glucose into two molecules of pyruvate, generating 2 
ATP molecules.
16
 The final step requires pyruvate kinase (PK), which exists as 
several isoforms, notably PKM1 and PKM2.
17
 In the presence of oxygen, pyruvate is 
usually converted to Acetyl CoA, which then enters the Krebs cycle, forming electron 
donors for OXPHOS, generating approximately 32 net ATP molecules.
18
 When 
oxygen is scarce or falls short of demand, pyruvate is shunted away from OXPHOS 
and gets converted into lactate by lactate dehydrogenase (LDH) to regenerate 
nicotinamide adenine dinucleotide (NAD+).
18,19
 Each of the steps within the 
glycolytic pathway is catalysed by a specific enzyme or enzyme complex. 
15
 Some of 





In tumours, proliferating tissue, and the mammalian retina, conversion of pyruvate to 
lactate occurs despite the presence of oxygen.
1,6,23




The biological drive that causes tumours and some other non-neoplastic cells to 
apparently forsake optimal ATP production remains somewhat speculative. Warburg 
initially hypothesised that the reliance on the glycolytic metabolism was secondary to 
development of mitochondrial defects within cancer cells, which impaired OXPHOS.
1
 
Albeit plausible, this hypothesis was rejected when subsequent studies demonstrated 
normal functioning mitochondria in most cancer cells.
24,25
 A more tenable explanation 




The metabolic requirements of tumour and proliferating cells 
Vander Heiden et al. publishing in Science, summarized a widely-accepted 
explanation for the existence of the Warburg effect in cancer. 
10
 In proliferating cells, 
glucose not only produces ATP, but also provides metabolic intermediates for 
biosynthesis (Fig. 1).
10
 Intracellular glucose can also be directed towards 
biosynthesis: into the pentose phosphate pathway (PPP) to generate nucleotides and 
NADPH (nicotinamide adenine dinucleotide phosphate, reduced), or to make the 
amino acids, serine and glycine, branching from glycolysis at phosphoglycerate.
10,26
 
The enzyme phosphoserine phosphatase (PSPT) is the final step in glucose-serine 




Proliferating cells have the ability to increase glycolytic ATP production under 
hypoxic conditions, but provided glucose is abundant, in normoxia, they direct 
metabolic pathways away from OXPHOS towards biomass synthesis. The ability to 
oscillate between biosynthesis and energy production provides proliferating tissue 
with a powerful metabolic strategy known as the “metabolic budget system”,28 a 
6 
phenomenon which goes hand-in-hand with the Warburg effect (Fig. 1). This strategy 
can be viewed as the presence of the Warburg effect in a tissue using glucose for 
biosynthesis.
28
 Such a phenomenon, however, has not yet been reported in a non-
proliferating tissue, such as the retina.  
 
The metabolic reprogramming 
The programming of cellular metabolism involves the interplay of various growth 
factor signaling pathways.
29,30




 mammalian target of rapamycin (mTOR),
32,33
 the proto-oncogene and 
tumor suppressor genes 
34,38
 have been implicated in the mediation of the Warburg 
effect. However, the focus has recently converged on pyruvate kinase isoform M2 





HIF-1 is a dimeric transcription factor, comprised of an oxygen regulated alpha 
subunit (HIF-1) and a constitutive beta subunit HIF-1b, also known as Arnt), that is 
essential for driving cellular responses to hypoxia.
36
 When oxygen is sufficient, the 
expression and activity of HIF-1 are inhibited.37 In hypoxia HIF-1 is stabilised and 
transcriptionally active; it partners with HIF-1 to transactivate a large set of target 
genes leading to various changes in cellular processes including the upregulation of 
glycolysis and the inhibition of OXPHOS. 
36,37
 Interestingly, HIF-1 has been shown to 
be active in many cancers, even in normoxia, 
37
 where it plays a key role in driving  
the Warburg effect.  
 
7 
Pyruvate kinase (PK) is a glycolytic enzyme which catalyses the conversion of 
phosphoenolpyruvate (PEP) into pyruvate, generating one molecule of ATP in the 
rate-limiting final step of glycolysis.
38,39
 There are 4 isoforms of pyruvate kinase in 
mammals: L – liver, R – red blood cell, M1- adult (muscle and brain), M2 – 
embryonic and tumour.
40
 Uniquely, PKM2 has an allosteric pocket not present in the 
other isoforms, that permits binding to phosphotyrosine peptides and fructose 1,6 
biphosphate (FBP).
8,41
 This structural configuration renders PKM2 vulnerable to 
various regulatory inputs. Whilst PKM1 forms a stable, constitutively active tetramer, 
PKM2 oscillates between the active tetrameric and the inactive dimeric (or 
monomeric) forms.
28,42
 The dimeric form has a low affinity for the substrate PEP, and 
lower activity than the tetrameric form.
42
 When the dimeric form dominates, PEP 
conversion becomes inefficient, and as a consequence glycolytic intermediates 
upstream of PEP accumulate and are available for biomass synthesis and cell 
proliferation.
28
 As the glycolytic intermediate, FBP accumulates, the reaction favours 
conversion of the dimeric form back to the tetrameric form and pyruvate is produced 
efficiently again. 
28,42
 These regulations of PKM2, labelled as the “metabolic budget 
system”, are proposed to control the anabolic biosynthesis versus energy production 
in tumour metabolism.
28





Although it was initially assumed that the switch from expression of physiological 
PKM1 to PKM2 is responsible for the Warburg effect in tumour cells, 
8
 subsequent 
experiments demonstrated PKM2 as the predominant pyruvate kinase isoform in both 
tumour and normal tissues. 
4546, 47
. PKM2 was also proposed to act as a co-activator of 
HIF-1 in the mediation of the Warburg effect in cancer cells, and PKM2 is also a 
8 
direct target gene of HIF-1. 
9,48
Other experiments have reported non-metabolic 
functions of PKM2 such as the ability to function as protein kinase, which may confer 
additional benefits in the promotion of the Warburg effect.
45, 46 
 
More recent studies however unfolded several sobering findings.
43,49,50
 Cortés-Cros et 
al observed that PKM2 knockdown did not affect the growth of established tumour.
49
 
In addition, the authors highlighted ongoing pyruvate production along with increased 
serine and glycine biosynthesis in dual PKM1 and PKM2 knockdown tumour cells.
49
 
One explanation would involve the shunting of accumulated upstream glycolytic 
intermediates into the serine synthetic pathway, in which serine is produced and 
subsequently converted into pyruvate.
26
 The existence of alternative glycolytic 
pathways involving not yet characterised enzymes had also been proposed.
51
 Israelsen 
et al then reported paradoxical acceleration of tumour growth with the loss of PKM2 
in mouse model of breast cancer.
50
 Similarly, Anastasiou et al demonstrated that high 




Collectively, these results highlighted two interesting points. Firstly, PKM2 
expression is not entirely essential in tumour growth. Secondly, overall high pyruvate 
kinase activity actually hinders tumour growth. This paradigm in fact fit snugly with 
the “metabolic budget system”, that high pyruvate kinase activity leads to depletion of 
glycolytic intermediates available for biosynthesis and therefore impairs cellular 
proliferation and growth. 
10, 28,43
 Because the activities of PKM2, determined by its 
conformation in either the highly active tetramer or the inactive dimer, are highly 
malleable to various regulatory inputs, preferential PKM2 expression confers an 
9 
advantageous metabolic flexibility to the differential metabolic needs of proliferating 





Mammalian retinal metabolism 
 
Glycolysis in mammalian retina 
The retina requires a high level of metabolism even in the resting state, attributable to 
the continuous energy-demanding processes that are required to maintain the neurons 
in an excitable state for phototransduction and neurotransmission, in addition to the 
maintenance of normal cellular function.
52
 The initial discovery of the high level of 
lactate production from explanted retina by Warburg and team sparked the 
unprecedented impetus for huge interest in the metabolism of mammalian retina.
1
 
Numerous experiments have subsequently reinforced Warburg’s original findings and 




In year 1951, Noell WK demonstrated the direct dependence of mammalian (rabbits 
and cats) retina function on glycolysis.
5
 The visual functions in these mammals as 
measured by electroretinogram (ERG), resisted the effect of anoxia but were highly 
susceptible to iodoacetate inhibition of glycolysis.
5
 Iodoacetate is an agent that 
selectively inhibits glycolysis whilst preserving mitochondrial OXPHOS.
5,53
 Loss of 
electrical activity and selective disappearance of the rod photoreceptor cells were 
observed following iodoacetate inhibition.
53
 In another in vivo study, Tornquist and 
Alm measured the arterio-venous differences in glucose, oxygen and lactate levels for 
both choroidal and retinal blood in pigs.
55
 The data recorded high concentration of 
10 
lactate in the venous blood. 
55
 Additionally, the total amount of oxygen extracted from 
choroidal and retinal blood flow combined only accounted for complete oxidation of 
37% of all the extracted glucose, reflecting the high glycolytic activities. 
55
 The 
majority of the glycolytic substrate was derived from the choroidal circulation, 




In 1975, Barry Winkler reported the capability of isolated rat retina to support 
electrical activity in the photoreceptors anaerobically, if significantly high glucose 
concentrations was provided, a level high enough to sustain maximal lactate 
production.
56
 Of note, the electrical activity was maintained at 80% for 30 minutes of 
anoxia but inevitably dropped to 40% of the aerobic value when a glucose 
concentration equivalent to that of rat retina in vivo was used.
56
 The results clearly 
showed the reliance of mammalian retina on glycolysis and its high metabolic 
adaptability whereby it can be driven into “overdrive” glycolytic mode to maintain 
near normal physiological functions in anoxia, provided that glucose is unlimited. 
Winkler expanded his experiments in rat retinas to analyse the aerobic versus the 
anaerobic effect on retinal lactate production, ATP content and electrophysiological 
recordings.
6
 These rat retinas demonstrated an obvious Pasteur effect, whereby 
increased glycolysis was observed in the anaerobic state, employed to maintain the 
portion of ATP which is otherwise generated via aerobic OXPHOS.
6
 Also perplexing 
were the findings of disproportionate reduction of lactate production by 50% when 
glucose concentration was decreased by 80% whilst the ATP level was maintained.
6
 
Interestingly, both ATP and lactate production plateaued after optimal oxygen and 
glucose concentrations were reached. 
6,57
 The paucity in the rise of both ATP and 
11 
lactate production might indicate that either the retinal metabolic capacity was 
exceeded, or the shunting of glucose catabolism into biomass synthesis occurred.  
 
The fact that glycolysis within mammalian retina occurs predominantly in the aerobic 
setting was substantiated by Wang et al which showed the lack of effect from induced 
hyperoxia in rabbit retina on the lactate production and glucose consumption.
58
 In 
Winkler’s elaborate, in vitro study of glucose metabolism in both normal and 
dystrophic rat retinas, 90% of the glucose utilized aerobically was used in 
glycolysis.
59
 Furthermore, an Ames et al experiment in isolated rabbit retina 
documented corresponding changes in the lactate level with neurotransmission, 
independent of oxygen consumption.
52
 The author postulated that neurotransmission 
through the inner retina was highly dependent on glycolysis. 
52
   
 
 
Higher glycolytic activities in the outer retina 
Vast majority of the aerobic glycolysis reportedly takes place in the outer retina, 
mainly in the photoreceptors.
60-63
 Graymore observed a greater than 50% reduction in 
the glycolytic activities within dystrophic rat retinas lacking photoreceptor cells when 
compared to normal rat retinas.
60,61
 Strong evidence was also described by Wang et al 
who ascertained the glucose consumptions in pig retina in vivo by measuring the 
arteriovenous differences in the glucose concentrations.
62,63
 The inner retina 
metabolised 21% of glucose via glycolysis, and 69% via oxidative metabolism in 
contrast to the outer retina which metabolised 61% of glucose via glycolysis and only 
12% via oxidative metabolism. 
62,63
 These results are consistent with the differential 
oxygen consumption reported in mammalian retina. 
64-66
 The deep inner plexiform 
12 
layer, the outer plexiform layer and the inner segments of photoreceptor have much 
higher oxygen consumptions as opposed to the outer segments of the photoreceptors 




Relative contribution of glycolysis versus OXPHOS in relation to retinal functioning  
All metabolic evidence for the Warburg effect in the retina comes from experiments 
on whole retinas, with no discrimination between the different retinal layers. 
5,52-54
 For 
these reasons, it has been fairly difficult to correlate the retinal metabolism to the 
cellular processes, and the exact contribution of glycolysis versus OXPHOS in retinal 
functioning remains estimative. Variations also exist across different mammalian 
species and with different experimental designs. 
52,54,62,67 
Reported contributions of 





 90% in rat,
59
 to 99% in cultured human retinal Müller cells.
71 
 
The highly glycolytic mammalian retina also confers protection against short-term 
anoxia, through upregulation of glycolysis, provided that glucose is abundant.
5,6,53,56
 
Noell demonstrated that retinal ganglion cells (RGCs) are susceptible to hypoxia and 
are the “weakest link in the chain” of visual perception when oxygen is scarce.68 The 
neuroprotective effect of glucose was supported by our previous research which 
indicated that an elevated vitreal glucose level at the time of acute
69
 or chronic retinal 
ischaemia
70
 or experimental glaucoma
71
 provides robust protection to the RGCs.  We 
recently demonstrated that, in vitro, this is predominantly due to glycolytic ATP 
production.
72
 The protective effect is abolished if the vitreous glucose is elevated post 
ischaemia.
73
 These results suggest that the RGCs can upregulate glycolysis during 
ischaemia to generate ATP (the Pasteur effect). Winkler et al. attempted to determine 
13 
whether cultured RGCs displayed the Pasteur effect,
74
 but unfortunately their 
methodology was flawed because they used an RGC-5 cell line, which was later 
recognized to be of photoreceptor origin.
75,76
 Hence, information about the Pasteur 
effect in RGCs remains incomplete. 
 
Nevertheless, experimental evidences have indicated that neither OXPHOS nor 
glycolysis are dispensable for optimal retinal metabolism and functioning.
6,52
 The 
essentiality of mitochondrial OXPHOS in mammalian retina functioning is seen in 
retinitis pigmentosa model.
77
 The IDH3B gene encodes for the B-subunit of NAD-
specific isocitrate dehydrogenase (NAD-IDH) which is required to catalyse the 
oxidation of isocitrate to alpha-ketoglutarate in the citric acid cycle of mitochondrial 
OXPHOS. IDH3B mutations in familial retinitis pigmentosa result in the impairment 
of mitochondrial OXPHOS. This may, in part, contribute to progressive rod and cone 
photoreceptor degeneration, characteristic of the disease.
77
 The notion of 
mitochondrial dysfunction and associated oxidative stress in retinitis pigmentosa is 




Explanation for the Warburg effect in mammalian retina 
We have recently published a teleological explanation for the presence of the 
Warburg effect in the mammalian retina: Even though the adult mammalian retina is 
non-proliferative, it shares similar biosynthesis requirements to neoplastic tissue due 
to the prodigious turnover of the opsin protein in the disc membranes of the 
photoreceptor outer segments.
11
 Each mammalian rod outer segment (ROS) consists 
of a stack of ~1500 distinct discs enclosed by the plasma membrane.
81,82
 
Approximately 60% of the dry weight of the disc membrane is protein, and opsin 
14 
comprises 90% of the protein content.
83
 Hence, rhodopsin forms a large structural 
component of the rod disc membrane. Rhodopsin, retinal-bound opsin, is a G protein-





In a landmark experiment using radioactively labelled methionine and 
radioautography tracing, Richard Young showed that rhodopsin was constantly 
renewed as the disc membranes moved in a sclerad direction along the ROS towards 
the retinal pigment epithelium in mouse, rat and frog retinas. 
85
 The rhodopsin 
turnover rate as measured by the position of radioactive band displacement, was 
notably faster in rats than in frogs. 
85
  Thus, the reason that the Warburg effect has 
evolved in the mammalian retina is simply because it has similar metabolic 
requirements to a proliferating tissue, owing to the constant rhodopsin turnover. The 
rhodopsin turnover rate parallels the degree of aerobic glycolysis found in different 
species.
85
 Furthermore, the relatively low rate of photoreceptor turnover in lower 
vertebrates is temperature dependent, increasing at higher temperatures,
85
 reflecting 




Also in accordance to this postulation, was the observation by Agathocleus et al 
which reported facultative aerobic glycolytic nature of developing Xenopus laevis 
frog and zebrafish retinas, to match the biosynthetic requirements.
86
 Glycolysis 
inhibition resulted in cellular apoptosis but OXPHOS interference had no deleterious 
consequence.
86






An alternate hypothesis to the high glycolytic process in the photoreceptors may 
involve the highly compartmentalized cellular configurations, with the confinement of 
mitochondria to the inner segment, while absent from the outer segment. 
82,87
 The 
dense aggregation of mitochondria in the ellipsoid region of the inner segment reflects 
the considerable reliance of this portion on oxidative energy.
87-89
 Supporting this was 
the finding of high concentration of malate dehydrogenase (an enzyme involved in 
OXPHOS) in the monkey photoreceptor inner segment, 30 times higher than that in 
the outer segment.
90
 On the contrary, measured LDH was significantly lower in the 
inner segment as compared to the outer segment. 
90
 The exclusion of mitochondria 





Aerobic glycolysis and lactate from Müller Cells 
In addition to the biosynthetic requirements of the photoreceptors, aerobic glycolysis 
and lactate production from Müller cell cultures has also been described. 
67
 The 
Müller cells are the predominant glial cells of the retina, and have been proposed as 
the primary storage sites for glycogen.
91
 The human Müller cells (HMC) metabolize 
glucose primarily via aerobic glycolysis, accounting for 99% of total glucose 
metabolism and the remaining 1% undergoes mitochondrial OXPHOS.
67
 This 
observation is consistent with the so-called astrocyte neuronal lactate shuttle 
hypothesis (ANLSH) in the brain.
92
 The ANLSH asserts that brain neurones use 
astrocyte-derived lactate as a primary energy source and that the delivery of lactate is 
calibrated by neuronal activity.
92
 There is evidence for and against this hypothesis and 
the matter remains highly controversial.
93
 Conceivably, a similar phenomenon exists 
in the retina with the Müller cells taking the place of the astrocytes.  
16 
 
Experimental findings also unveiled the multipotent differentiative capability of the 
adult HMC, whereby it can undergo differentiation into retinal neurons, astrocytes, 
oligodendrocytes
94
 and also rod photoreceptors.
95
 Reportedly, the differentiation into 
rod photoreceptors is six-fold faster than conventional pluripotent stem cells. 
95
 The 
unique capability of adult HMC to proliferate and differentiate likely explains its 
inherent metabolic preference for aerobic glycolysis, which is better suited for this 
role. Recent evidence indicates that Müller cell ablation in a transgenic model causes 
photoreceptor degeneration related to loss of neurotrophic support.
96
 Whether the 
mechanisms driving lactate production in Müller cell cultures also involve PKM2 is 
completely unknown. 
 
Lactate dehydrogenase in cancer and the retina 
Lactate dehydrogenase (LDH) is a tetrameric enzyme comprising two major subunits 
A and/or B, (encoded by the Ldh-A and Ldh-B genes) resulting in five isoenzymes 
(A4, A3B1, A2B2, A1B3, and B4) that catalyse the forward and backward conversion 
of pyruvate to lactate. LDHA (LDH-5, M-LDH, or A4), which is the predominant 
form in skeletal muscle, kinetically favours the conversion of pyruvate to lactate.
97,98
 
LDHB (LDH-1, H-LDH, or B4), which is found in heart muscle, converts lactate to 
pyruvate that is further oxidized in mitochondria.
97,98
 Cancers also utilize the LDHA 
form, (even when oxygen is abundant); hence, the quantification of LDHA in cancer 
has become a routine surrogate marker of the Warburg effect, providing diagnostic 





The mammalian retina also expresses relatively high levels of LDHA, typical of a 
tumour.
100-102
 Saavedra et al reported the exceptionally high amount of LDHk 
(synonymous with LDH-5) activity in rat, mouse, guinea pig retina, equivalent to the 
level measured in human cancer cells.
101,102
 Lower vertebrates such as turtle, toad and 
frog that do not display the Warburg effect, have correspondingly much lower LDH-5 
activities.
102
 Graymore, publishing in Nature in 1964, noted that the expression of the 
LDHA isoenzyme in the retina was reduced in rats with inherited “retinitis 
pigmentosa”, characterized pathologically by loss of the photoreceptors.100 This 
observation indicated that the photoreceptors were principally responsible for the 
retinal lactate production and also supported evidence that the photoreceptors were 





PKM2 and HIF-1α in mammalian retina 
We have recently found an evidence for the presence of PKM2 and constitutive 
expression of low level HIF-1α in the rat retina (unpublished data). Hughes et al have 
earlier reported the presence of stabilized HIF-1α in normal physiological human and 
rat retinas.
103
. The presence of PKM2 in mouse retina was demonstrated by 
Morohoshi et al using purified IgG specific for the M2 isoform from individuals with 
age-related macular degeneration (ARMD).
104
 The authors proposed that PKM2 may 
correlate with the severity and progression of ARMD.
104
 Conceivably, the presence of 
PKM2 antibodies in ARMD has a causal relation but, to our knowledge, remains 
untested.  These important findings of the coexpression of PKM2 and HIF-1α in 
normal mammalian retina suggest that these molecular factors likely play a role in 




Anti cancer therapy targeting glycolysis and the Warburg effect 
Advances in the understanding of the molecular mechanism of the Warburg effect in 
cancer have motivated countless efforts to develop targeted therapies as novel cancer 
treatment.
105-113
 Variable successes have been reported with PKM2 modulation in 
vitro and in vivo animal studies. 
43,50,111-113
 Besides targeting PKM2, many other drugs 
that target different stages of glycolysis are also under preclinical development. 
105-110
 
However, the extent of toxicities of these drugs towards normal, metabolically active 
tissues utilizing glycolysis in humans is largely unknown.  
 
The obligatory reliance of mammalian retinal metabolism and functioning on 
glycolysis as highlighted in this review raises a huge concern on the potential 
toxicities of these therapies towards the retina, especially the photoreceptors. Any 
disruption to the key metabolic pathway essential for physiological maintenance of 
continuous photoreceptor renewal, energy production, phototransduction and 
neurotransmission will likely result in significant cellular disturbance or irreversible 
cell death within the retina. Also, the key aspects of the molecular mechanism 




Ongoing research endeavours are therefore vital to continue to fill the gaps in our 
knowledge and guide us towards a better understanding of retina biology and 
metabolism. Such progresses may hopefully lead to breakthrough findings in the 
treatment of various retinal diseases and also aid clinicians to predict the potential 
adverse effects to the retina of cancer treatments targeting the Warburg effect. At the 
19 
same time, the notion of targeting the Warburg effect and PKM2 as a therapeutic 














Fig. 1 Metabolic budget system and the Warburg effect. PKM2 exists as an active 
tetrameric form and an inactive dimeric form. Its transition is found to be regulated by 
fructose 1,6 biphosphate, serine, reactive oxygen species and phosphotyrosine 
peptide. PKM2 is also a co-activator and a target gene of HIF-1α. We propose that 
glucose-derived amino acids are required for rhodopsin synthesis, and that the 
Warburg effect is HIF-dependent.  
PPP = pentose phosphate pathway; PEP = phosphoenolpyruvate 
PKM2 = pyruvate kinase M2; HIF-1α = hypoxia-inducible factor-1alpha; LDHA = 
lactate dehydrogenase A; PDH = pyruvate dehydrogenase; PDK1 = pyruvate 
dehydrogenase kinase 1; PSPT = phosphoserine phosphatase; FBP = fructose 1,6 
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